We previously reported that association of endothelial nitric oxide synthase (eNOS) with actin increases eNOS activity. In the present study, the regulation of activity of eNOS by the actin cytoskeleton during endothelial growth was studied. We found that eNOS activity in pulmonary artery endothelial cells (PAEC) increased when cells grew from preconfluence to confluence. The eNOS activity was also much greater in PAEC in higher density than those in lower density, suggesting that the increase in eNOS activity during cell growth is caused by increase in cell density. Although eNOS protein contents were also increased when endothelial cells grew from preconfluence to confluence, the magnitude of increase in eNOS activity was much higher than the increase in eNOS protein content, suggesting that post-translational mechanisms played an important role in the regulation of eNOS activity during endothelial growth. Confocal fluorescence microscopy revealed that eNOS was colocalized with G-actin in preconfluent cells in the perinuclear region, and with both G-actin in the perinuclear area and with cortical F-actin in the plasma membrane in confluent cells. There was more β-actin co-immunoprecipitated with eNOS in the Triton-X-100-soluble fraction in the confluent cells in later growth phase and in high density. Decrease in eNOS association with β-actin by silencing β-actin expression using β-actin siRNA causes inhibition of eNOS activity, NO production, and endothelial monolayer wound repair in PAEC. Moreover, incubation of PAEC with cytochalasin-D and jasplakinolide resulted in increases in eNOS/actin association and in eNOS activity without changes in eNOS protein content. Yeast two-hybrid experiments suggested a strong association between the eNOS
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Introduction
The endothelial isoform of nitric oxide synthase (eNOS) catalyzes the reaction to produce nitric oxide (NO) from L-arginine. NO plays an important role in the regulation of vascular tone, platelet aggregation, angiogenesis, and smooth muscle cell proliferation (2, 8, 11) . It is known that eNOS is tightly regulated by a variety of transcriptional, posttranscriptional and posttranslational mechanisms. Recent evidence indicates that the actin cytoskeleton regulates eNOS activity (13, 20, 22) . The actin cytoskeleton, which is critical for regulation of endothelial cell integrity and motility, consists of filamentous polymerized actin (F-actin), arranged as a string of uniformly oriented globular actin (G-actin) subunits in a tight helix (4) . In endothelial cells, there are two groups of F-actin: stress fibers, which are linked to the cell membrane at focal adhesion sites, and cortical F-actin, which is located in a plasma membrane subdomain (5, 25) . Disruption of actin filaments by the Rho inhibitor Clostridium botulinum C3 transferase, by cytochalasin D, or by swinholide or decreases in actin stress fiber formation by overexpression of a dominant-negative Rho mutant increase eNOS expression (13, 20, 22) . We have reported that the actin cytoskeleton is associated with eNOS protein and plays an important role in posttranslational regulation of eNOS activity (20) .
During endothelial growth the actin cytoskeleton undergoes dramatic reorganization to facilitate cell migration and trafficking of intracellular proteins and organelles. For example, in the transition from a resting state to a proliferative state during endothelial monolayer wound repair, endothelial cells lose cortical actin and actin stress fibers became more prominent (14) . A dynamic alteration in eNOS activity is also observed during endothelial cell growth. eNOS activity is much greater in confluent quiescent cells than in preconfluent proliferating cells (10, 24) . In the present study, we examined the interaction of the actin cytoskeleton and eNOS LCMP-00444-2004:R1 during growth of pulmonary artery endothelial cells (PAEC). Our results indicate that there is a direct association of actin with eNOS protein and that increased association of actin with eNOS is responsible for increased eNOS activity in confluent quiescent PAEC.
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Materials and Methods
Reagents and materials
Human eNOS cDNA was a kind gift of Dr. Philip Marsden (University of Toronto, Toronto, Ont, Canada). Human β-actin cDNA was purchased from BD Bioscience Clontech (Palo Alto, CA). Cytochalasin-D and jasplakinolide were purchased from Calbiochem (La Jolla, CA). L- 
Preparation of PAEC in different growth stages
PAEC were obtained from the main pulmonary artery of six to seven month old pigs and were cultured as previously reported (18) . PAEC in third and sixth passage were used. Cells in different growth stages were prepared in two ways. First, for time-dependent growth, confluent cells were trypsinized and plated at a density of 0.3 x 10 6 per 100 mm dish. After an initial incubation for 48 h in RPMI-1640 containing 10% FBS, designated as day 1, cells were harvested every 24 h and frozen at -70°C until all samples were collected. At day 3 the medium was discarded and replaced with fresh RPMI-1640 containing 10% FBS. A change in medium at this point did not affect eNOS activity. Cells reached confluence at day 4 (6 days after plating).
Confluence and subconfluence were assessed using an inverted phase-contract microscope at 
Measurement of intracellular NO production and NO release in culture medium
NO production in intact single PAEC was determined using the NO indicator dye DAF-FM as recently described (27) . Confluent and preconfluent (60% of confluence as judged by visual analysis) cells were incubated with 10 µmol/L DAF-FM for 10 min at room temperature after which direct visualization of NO production with the fluorescent indicator was performed using a laser-scanning confocal microscope with excitation and emission maxima at 495 and 515 nm, respectively. The fluorescence intensities of five cells randomly selected in one observation field were quantitated using LSM 510 (version 3.0 SP3) software for the Carl Zeiss Laser Scanning Microscope for 30 min. The results are expressed as ratio to control for each cell. NO release in the culture medium was measured by determining nitrate formation using a nitric oxide quantitation kit (Active Motif, Carlsbad, California).
Determination of eNOS activity
eNOS activity was determined by measuring the formation of L-
3 H] arginine as previously described (21) . Cells were scraped and homogenized in a Tris-HCl buffer containing EDTA and EGTA. Homogenates were centrifuged at 100,000 x g for 60 min at 4°C, and total membrane pellets were resuspended in buffer containing 2.5 mmol/L CaCl 2 . The resulting suspensions were used for monitoring L- previously (21) . The specific activity of NOS is expressed as L-citrulline pmol/L/min/mg protein and reflects eNOS activity because our cells do not exhibit iNOS activity (26) .
Immunofluorescence confocal microscopy
Confluent and preconfluent (about 60% confluence) PAEC plated on glass coverslips were fixed in 4% paraformaldehyde and incubated with 0.1% Triton X-100 for 10 min and with 5% goat serum for 30 min. eNOS was stained with monoclonal anti-eNOS antibody labeled with FITC goat anti-mouse IgG. F-actin and G-actin were stained with Texas red -conjugated phalloidin and deoxyribonuclease I respectively. eNOS and actin were detected using a Zeiss LSM 510 laser scanning confocal microscope.
Separation of Triton X-100-insoluble fraction from Triton X-100-soluble fraction
Separation of proteins in Triton X-100-soluble and insoluble fractions was done as described previously (20) . Briefly, PAEC were washed with ice-cold PBS and then scraped into 1% Triton X-100 buffer. The lysates were incubated at 4°C for 20 min and centrifuged at 100,000 x g for 20 min. The supernatants constituted the Triton X-100-soluble fraction and were used for Western blot analysis and immunoprecipitation with eNOS antibody as described in the following sections. The pellets constituted the Triton X-100-insoluble fractions, which were lysed in RIPA buffer at 4°C for 20 min and centrifuged at 14,000 g for 20 min. The supernatants were then used in Western blot analysis.
SDS-PAGE and Western blotting
Cells were plated as described above for growth-or density-dependent experiments.
Alternatively, preconfluent and confluent cells were exposed to appropriate reagents or to 
Coimmunoprecipitation of eNOS and actin
To study the association of eNOS with β-actin, coimmunoprecipitation of eNOS and actin were performed. Triton X-100-soluble and insoluble fractions of total lysates were used for immunoprecipitation as described previously (20) . Lysates were incubated with monoclonal anti- after transfection, PAEC were lysed. The protein contents of eNOS and β-actin, eNOS activity, and eNOS association with β-actin were measured.
Assay of endothelial monolayer wound repair
In order to evaluate the functional consequence of eNOS association with β-actin, we measured endothelial monolayer wound repair in endothelial cells in which eNOS association with β-actin is reduced by β-actin siRNA. The endothelial monolayer wound repair assay was performed as previously described (19) . Three days after transfection of β-actin siRNA, a cellfree wound zone was created by scraping the monolayer with a sterile pipette tip. The wound width of monolayers in mm was measured under the microscope. Then monolayers were washed and incubated with RPMI 1640 containing 2% FBS, then wound width was measured again after 16 h. Endothelial monolayer wound repair distance is expressed as the difference between the width of the wound before and after incubation (mm).
Detection of interaction of eNOS and actin by yeast two hybrid system
Interaction of eNOS and actin protein in yeast two hybrid system Matchmaker II (BD Bioscience Clontech, Palo Alto, CA) was performed according to the manufacturer's protocol. 
Statistical analysis
In each experiment, control and experimental endothelial cells were matched for cell line, age, seeding density, number of passages, and number of days postconfluence to avoid variation in tissue culture factors that can influence the measurement of eNOS activity and eNOS protein analysis. Results are shown as mean ± SE in experiments. Student's paired t-test was used to determine the significance of differences between the means of treated and control groups. A Pvalue of < 0.05 was taken as significant.
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Results
eNOS activity and eNOS protein level increased during endothelial cell growth
To reveal the alteration of eNOS in endothelial cell growth, we plated PAEC at low density of 0.3 x 10 6 /100mm dish. At day one, (48 h after plating), the endothelial cells grew to 50% confluence. At day two, day three, and day four, confluence stages were 75%, 90%, and Figure 1 ) showed that the increase in eNOS activity was much higher than the protein level increase, suggesting that a posttranslational regulatory mechanism was primarily, but not exclusively, responsible for the increased eNOS activity in confluent (day 4) and postconfluent (day 5) endothelial cells.
eNOS activity and eNOS protein level increased as cell density increased
To determine whether the increase of eNOS activity during cell growth is caused by an increase in cell density, we plated PAEC at cell densities of 0.3 x 10 6 , 0.6 x 10 6 , 1.0 x 10 6 , and LCMP-00444-2004:R1
1.5 x 10 6 per 100 mm dish, respectively. 48 h after plating, the cells reached 50%, 75%, 90%, and 100% confluence. As shown in panel A of Figure 2 , eNOS activity was significantly higher in higher density cell cultures than in lower density cell cultures. eNOS protein content was also elevated in PAEC at high density without changes in the protein content of GADPH (panel B of Figure 2 ). However, the magnitude of the increase in eNOS activity was much greater than that in eNOS protein level (panel C of Figure 2 ). These data suggest that the alterations in eNOS activity and protein content during endothelial cell growth are due to increases in cell density.
Increase of NO production in confluent versus preconfluent cells
To evaluate whether higher eNOS activity in confluent cells is associated with increased NO production, NO production in confluent versus preconfluent (60% confluence) cells was determined using DAF-FM as a fluorescent substrate by using laser-scanning confocal microscopy of single cells. As shown in Figure 3 , NO production was higher in confluent cells than in preconfluent cells (60% confluence). The increase in NO production corresponded to the increase in eNOS activity, suggesting that higher eNOS activity in confluent cells resulted in higher NO production.
Colocalization of eNOS with actin in preconfluent and confluent endothelial cells
Intracellular localization of eNOS protein is an important factor regulating eNOS activity (6, 7, 23) . We analyzed the localization of eNOS protein in preconfluent and confluent cells by Figure 6 ), similar to the increased eNOS/G-actin interaction observed in cells at later growth stages. We found no significant differences in the amounts of Hsp90 and Caveolin-1 proteins co-precipitated with eNOS from Triton X-100-soluble fractions from cells at different density (panel B Figure 6 ). These data indicate that during cell growth or during the increase of cell density eNOS/β-actin (G-and F-actin) interaction increased and these increases were correlated with higher eNOS activity in confluent cells.
Cytochalasin-D-induced disruption of the actin cytoskeleton increases eNOS-actin interaction and eNOS activity
To confirm that changes in the actin cytoskeleton structure specifically influence eNOS activity, we treated PAEC with cytochalasin-D, a disrupter of the actin cytoskeleton. We found . These data indicate that cytochalasin-induced increases in the amount of actin in Triton X-100-soluble fractions resulted in greater association of β-actin with eNOS in this fraction and was associated with increased eNOS activity.
Jasplakinolide-induced actin reorganization increases eNOS-actin interaction and eNOS activity
To continue studying the role of the actin reorganization in regulating the eNOS-actin interaction, we stabilized actin polymers with jasplakinolide which promotes actin polymerization and prevents an increase in G-actin. In confluent PAEC treated with 10 nM, 50
nM, or 100 nM jasplakinolide for 24 h, the level of Triton X-100-insoluble actin increased in a dose-dependent fashion and the level of Triton X-100-soluble actin decreased insignificantly (panel B of Figure 8 ). Unexpectedly, eNOS activity was much higher in jasplakinolide-treated cells (panel A of Figure 8 ). To determine whether this higher eNOS activity was due to alteration in the association of eNOS with β-actin, co-immunoprecipitation of eNOS and β-actin in Triton X-100-soluble fraction was performed. We found that there was more β-actin protein coprecipitated with eNOS from Triton X-100-soluble fractions derived from jasplakinolide-treated cells (panel C of Figure 8 ), indicating that the elevation of eNOS activity was caused by increased association of β-actin with eNOS.
Silencing β-actin expression decreases eNOS/β-actin association, eNOS activity, and endothelial monolayer wound repair
To determine whether decreasing association of β-actin to eNOS inhibits eNOS activity, the gene expression of β-actin was silenced using siRNA. As shown in Figure 9 A and 9B, LCMP-00444-2004:R1 transfection of PAEC with β-actin siRNA resulted in a significant decrease in β-actin protein content in cell lysates and in precipitates brought down by antibody directed against eNOS, indicating that silencing β-actin expression reduces β-actin association with eNOS. Moreover, PAEC with reduced β-actin association with eNOS manifested a decrese in eNOS activity ( Figure 9C ) and a decrease in NO production ( Figure 10A ) and in monolayer wound repair ( Figure 10B ). The presence of the NO donor, NOC-18, prevented the reduction in monolayer wound repair, suggesting that decreased wound repair is not caused by endothelial structural damage but by decreased NO production.
Direct interaction of eNOS and β-actin in yeast two-hybrid system
To determine whether the eNOS-actin association was a direct interaction between eNOS and β-actin, yeast two-hybrid experiments were performed. We found that β-galactosidase activity was much higher in the co-transformants of eNOS oxygenase domain and β-actin than in those of eNOS reductase domain and β-actin or in those of eNOS middle part and β-actin (panels A, B of Figure 11 ). Consistent with these results, there were more colony numbers in the cotransformants of eNOS oxygenase domain and β-actin than in those of eNOS reductase domain and β-actin or in those of eNOS middle part and β-actin (panel C of Figure 11 ). Co-transformants of plasmids BD-oxy, BD-red, and BD-mid with empty pADT-7 and co-transformats of AD-β-actin with empty pGBKT-7 did not produce any β-galactosidase activity and yeast colonies.
These results indicate that eNOS can directly interact with the actin protein.
The binding site appears to be located in the eNOS oxygenase domain.
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Discussion
In the present study, we have found that a dynamic alteration in eNOS activity is induced during PAEC growth. When PAEC grow from preconfluence to confluence, eNOS activity increases and continues to increase after cells reach confluence. The increase in eNOS activity is accompanied by increased NO production in confluent cells versus preconfluent cells. The In the last several years, a large body of evidence has accumulated showing that the actin cytoskeleton associates with eNOS and regulates eNOS activity (10, 13, 20, 28) . Venema et al (23) reported that there is a significant amount of eNOS in the Triton X-100-insoluble portion (the actin cytoskeleton) of aortic endothelial cells. We have reported that eNOS is co-localized with cortical F-actin at the plasma membrane and with G-actin in the perinuclear region (Golgi complex) (20) , and incubation of purified eNOS with F-actin and G-actin results in significantly increased eNOS activity (20) . In the present study, our results show that in preconfluent PAEC eNOS is co-localized with G-actin in the perinuclear region but not with F-actin which presents in the form of stress fibers. In the confluent cells, F-actin is in the form of cortical F-actin instead of stress fibers, and eNOS is co-localized with cortical F-actin at the plasma membrane and with G-actin in the perinuclear area. Corresponding to observations in confocal fluorescence microscopy, we found increased eNOS protein contents in Triton X-100-insoluble fractions accompanied by increased β-actin content. In addition, there was more β-actin associated with eNOS in the Triton X-100-soluble fraction in confluent cells in later growth stages and in high density states, suggesting that increased association of actin with eNOS is an important post-
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translational mechanism responsible for greater eNOS activity in confluent PAEC. This conclusion is further supported by the observation that the decrease in eNOS association with β-actin secondary to silencing β-actin expression causes inhibition of eNOS activity, NO production, and endothelial monolayer wound repair in PAEC. Moreover, we have found that increases in the association of β-actin with eNOS by cytochalasin-D and jasplakinolide are accompanied by corresponding increases in eNOS activity. Cytochalasin-D is able to decrease and jasplakinolide to increase actin polymerization state. However, both agents induce increases in the association of β-actin with eNOS and in eNOS activity. We have previously reported that stabilization of F-actin by phalloidin decreases eNOS activity and association of eNOS to Gactin in PAEC (20) . Although two actin polymerization agents, jasplakinolide and phalloidin, have different effects on eNOS activity and eNOS/actin association, eNOS activity is positively correlated to its association with G-actin. Taken together, these results suggest that it is the eNOS/actin association rather than the actin polymerization state that affects eNOS activity.
Although we can not exclude the possibility that association of eNOS with the actin cytoskeleton is achieved indirectly through other eNOS interacting proteins, our data indicate that eNOS has a direct interaction with actin. In vitro incubation of purified eNOS with F-actin and G-actin resulted in significant increases in eNOS activity (20) . Moreover, in the present study, the yeast two hybrid experiments suggest a strong association of the eNOS oxygenase domain with β-actin. The mechanism for enhancement of eNOS activity by actin-eNOS interaction is not known. An increase in eNOS dimerization does not appear to be involved based on preliminary unpublished data from our laboratory. Further experiments are needed to confirm the precise actin binding site within the eNOS oxygenase domain and to identify the mechanism for enhancement of eNOS activity by actin-eNOS interaction.
Although several labs have reported that eNOS activity is greater in confluent endothelial cells (10, 24) , opposite findings also have been reported. Arnal et al (1) reported that eNOS activity and protein levels were lower in confluent bovine aortic endothelial cells (AOEC).
Zollner et al (29) showed that specific eNOS activity was upregulated in proliferating bovine atrial endothelial cells (BAtEC) and was downregulated in quiescent BAtEC. Recently,
Bayraktutan ( confluent aortic endothelial cells, the distribution of F-actin was diffuse, whereas F-actin was mainly in cortical F-actin. The aortic endothelium withstands higher blood pressure, so it may need intense and diffuse actin filaments. The pulmonary endothelium is subjected to much lower pressure and thus may need a more prominent cortical actin to facilitate tight intercellular junctions to preserve gas exchange. Another difference between our results and Searles' results in AOEC is that Searles et al reported that 500 nM jasplakinolide caused an increase in eNOS mRNA in aortic endothelial cells. We found that 500 nM jasplakinolide was cytotoxic to porcine PAEC. We found that jasplakinolide (10-100 nM) increased actin/eNOS association and eNOS activity without causing significant changes in eNOS protein content, suggesting that increased association of actin with eNOS protein results in greater eNOS activity. eNOS activity and NO production were not measured in the experiments of Searles et al (16) . The relative density was expressed as ratio to day 1. 
